BioCentury | Mar 9, 2015
Finance

Column's creations

...one company, which was developing a prodrug approach for cancer. TCG invested $4.5 million in Cyterix Pharmaceuticals Inc....
BioCentury | Sep 5, 2011
Strategy

Back to School 2011: Innovation & collaboration

...COG), Arcadia, Calif. Columbia University , New York, N.Y. Convergence Pharmaceuticals Ltd. , Cambridge, U.K. Cyterix Pharmaceuticals Inc....
...diseases; peptide therapeutics company Bicycle Therapeutics Ltd. ; ion channel company Convergence Pharmaceuticals Ltd. ; Cyterix Pharmaceuticals Inc....
BioCentury | Jun 13, 2011
Company News

Cyterix Pharmaceuticals Inc. board of directors update

Cyterix Pharmaceuticals Inc. , San Francisco, Calif. Business: Cancer Appointed: Lutz Giebel, managing partner of SV Life Sciences; and Tim Kutzkey, partner at The Column Group WIR Staff cancer...
BioCentury | Jun 13, 2011
Financial News

Cyterix Pharmaceuticals completes venture financing

Cyterix Pharmaceuticals Inc. , San Francisco, Calif. Business: Cancer Date completed: 6/7/11 Type: Venture financing Raised: $9.2 million Investors: The Column Group; SV Life Sciences WIR Staff cancer...
BioCentury | Jun 13, 2011
Emerging Company Profile

Cyterix: CYPing on prodrugs

...active in both cell types, or are activated only in specific cells within solid tumors. Cyterix Pharmaceuticals Inc....
...which has granted Cyterix exclusive, worldwide rights to the technology. Companies and Institutions Mentioned Cyterix Pharmaceuticals Inc....
...Calif. Threshold Pharmaceuticals Inc. (NASDAQ:THLD), Redwood City, Calif. University of Dundee , Dundee, Scotland Sidebars Cyterix Pharmaceuticals Inc....
Items per page:
1 - 5 of 5
BioCentury | Mar 9, 2015
Finance

Column's creations

...one company, which was developing a prodrug approach for cancer. TCG invested $4.5 million in Cyterix Pharmaceuticals Inc....
BioCentury | Sep 5, 2011
Strategy

Back to School 2011: Innovation & collaboration

...COG), Arcadia, Calif. Columbia University , New York, N.Y. Convergence Pharmaceuticals Ltd. , Cambridge, U.K. Cyterix Pharmaceuticals Inc....
...diseases; peptide therapeutics company Bicycle Therapeutics Ltd. ; ion channel company Convergence Pharmaceuticals Ltd. ; Cyterix Pharmaceuticals Inc....
BioCentury | Jun 13, 2011
Company News

Cyterix Pharmaceuticals Inc. board of directors update

Cyterix Pharmaceuticals Inc. , San Francisco, Calif. Business: Cancer Appointed: Lutz Giebel, managing partner of SV Life Sciences; and Tim Kutzkey, partner at The Column Group WIR Staff cancer...
BioCentury | Jun 13, 2011
Financial News

Cyterix Pharmaceuticals completes venture financing

Cyterix Pharmaceuticals Inc. , San Francisco, Calif. Business: Cancer Date completed: 6/7/11 Type: Venture financing Raised: $9.2 million Investors: The Column Group; SV Life Sciences WIR Staff cancer...
BioCentury | Jun 13, 2011
Emerging Company Profile

Cyterix: CYPing on prodrugs

...active in both cell types, or are activated only in specific cells within solid tumors. Cyterix Pharmaceuticals Inc....
...which has granted Cyterix exclusive, worldwide rights to the technology. Companies and Institutions Mentioned Cyterix Pharmaceuticals Inc....
...Calif. Threshold Pharmaceuticals Inc. (NASDAQ:THLD), Redwood City, Calif. University of Dundee , Dundee, Scotland Sidebars Cyterix Pharmaceuticals Inc....
Items per page:
1 - 5 of 5